Description
Also known as Do-It-Yourself (DIY) biology, biohacking is one of the revolutionary change in the field of synthetic biology. It is done by people with an urge of innovation and development of new products that can blend various aspects of synthetic biology and technology. Biohackers are people who perform lab experiments to explore new possibilities of biotechnology, molecular biology, genetic engineering and many other aspects of biology. They perform various experiments on the body, for instance, inserting microchips to control stress level or monitor heart rate.
The global biohacking market is segmented on the basis of type, product, application, and end user.
On the basis of type, market is segmented into outside biohacking, and inside Biohacking, with outside biohacking being the largest market.
On the basis of product, the market is segmented into sensors, smart drugs, strains, and others
On the basis of application, the market is segmented into synthetic biology, genetic engineering, forensics sciences, diagnosis & treatment, drug testing, and others. Synthetic biology is the largest market.
On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, forensics laboratories, and others.
Key Players:
The leading market players in the global Biohacking market include Fitbit, Inc. (U.S.), Apple (U.S.), Synbiota (Canada), THE ODIN (U.S.), HVMN, Inc. (U.S.), Thync Global Inc., U.S.A. (U.S.), Moodmetric (U.S.), and others.
Study objectives of biohacking market:
To provide insights about factors influencing and affecting the market growth
To provide historical and forecast revenues of the market segments and sub-segments with respect to regional and country-level markets
To provide historical and forecast revenue of the market segments based on types, products, applications, end users, and its sub-segments.
To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market.
Target Audience:
• Medical devices manufacturers
• Medical devices distributors
• Hospitals & Clinics
• Potential investors
• Key executive (CEO and COO) and strategy growth manager
Key Finding
• Outside biohacking segment accounted for the largest market share in 2016 which is valued at USD 3,712.01
• Smart drugs segment accounted for the largest market share in 2016
• Americas region captures the largest market and is expected to reach USD 10573.53 million by 2023
• Globally, Asia Pacific the fastest growing region in the global biohacking market.
The reports also cover country level analysis:
• America
• North America
o U.S.
o Canada
• Latin America
• Europe
• Western Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest Of Western Europe
• Eastern Europe
• Asia-Pacific
• Japan
• China
• India
• Republic of Korea
• Rest of Asia-Pacific
• Middle East & Africa
• Middle East
• Africa
1 Report Prologue 15
2 Market Introduction 19
2.1 Introduction 19
2.2 Scope of Study 19
2.3 Research Objective 20
2.4 Assumptions & Limitations 20
2.4.1 Assumptions 20
2.4.2 Limitations 20
2.5 Market Structure 21
3 Research Methodology 22
3.1.1 Primary Research Methodology 23
3.1.2 Secondary Research Methodology 24
3.1.3 Market Share Analysis 25
3.1.4 Trade Analysis 25
3.2 Forecast Model 26
4 Market Dynamics 27
4.1 Introduction 27
4.2 Drivers 28
4.2.1 Rising prevalence of chronic disease (45%) 28
4.2.2 Growing awareness about biohacking (25%) 29
4.2.3 Increasing demand for innovative medical devices and sensors (30%) 30
4.3 Restraints 31
4.3.1 Lack of cyber security practices 31
4.4 Opportunities 32
4.4.1 Technological advancement 32
4.5 Mega Trends 32
4.5.1 Exploration of future biohacking products on rise 32
4.6 Macroeconomic indicators 33
5 Market Factor Analysis 34
5.1 Value Chain Analysis 34
5.1.1 Primary activities 34
5.1.2 Secondary activities 35
5.2 Porters Five Forces Model 36
5.2.1 Bargaining Power of Suppliers 37
5.2.2 Bargaining Power of Buyers 37
5.2.3 Threat of New Entrants 37
5.2.4 Threat of Substitutes 37
5.2.5 Intensity of Rivalry 38
6 Global Biohacking Market, By Type 39
6.1 Introduction 39
6.2 Outside Biohacking 40
6.3 Inside Biohacking 40
7 Global Biohacking Market by Product 41
7.1 Introduction 41
7.2 Smart Drugs 42
7.3 Sensors 44
7.4 Strains 45
7.5 Others 46
8 Global Biohacking Market by Application 47
8.1 Introduction 47
8.2 Synthetic Biology 48
8.3 Genetic Engineering 49
8.4 Forensic science 51
8.5 Diagnosis & Treatment 51
8.6 Drug testing 53
8.7 Others 53
9 Global Biohacking Market, By End User 54
9.1 Introduction 54
9.2 Pharmaceutical & Biotechnology Companies 55
9.3 Forensic Laboratories 55
9.4 Others 56
10 Global Biohacking Market, By Region 57
10.1 Introduction 57
10.2 Americas 58
10.2.1 U.S. 63
10.2.2 Canada 65
10.2.3 South America 68
10.3 Europe 72
10.3.1 Germany 76
10.3.2 France 79
10.3.3 U.K 82
10.3.4 Italy 85
10.3.5 Spain 88
10.3.6 Rest of Western Europe 91
10.3.7 Eastern Europe 94
10.4 Asia Pacific 98
10.4.1 Japan 103
10.4.2 China 105
10.4.3 India 108
10.4.4 Australia 111
10.4.5 Republic of Korea 114
10.4.6 Rest of Asia Pacific 117
10.5 Middle East & Africa 121
10.5.1 United Arab Emirates 125
10.5.2 Saudi Arabia 128
10.5.3 Oman 131
10.5.4 Kuwait 134
10.5.5 Qatar 137
10.5.6 Rest of Middle East & Africa 140
11 Company Landscape 144
11.1 Introduction: Key Players 144
11.2 Company Share Analysis 144
12 Company Profile 145
12.1 Fitbit, Inc. 145
12.1.1 Company Overview 145
12.1.2 Financials 145
12.1.3 Products 145
12.1.4 Strategy 145
12.1.5 Key Developments 145
12.2 Apple 146
12.2.1 Company Overview 146
12.2.2 Financials 146
12.2.3 Products 146
12.2.4 Strategy 146
12.2.5 Key Developments 146
12.3 Synbiota 147
12.3.1 Company Overview 147
12.3.2 Financials 147
12.3.3 Products 147
12.3.4 Strategy 147
12.3.5 Key Developments 147
12.4 THE ODIN 148
12.4.1 Company Overview 148
12.4.2 Financials 148
12.4.3 Products 148
12.4.4 Strategy 148
12.4.5 Key Developments 148
12.5 HVMN, Inc. 149
12.5.1 Company Overview 149
12.5.2 Financials 149
12.5.3 Products 149
12.5.4 Strategy 149
12.5.5 Key Developments 149
12.6 Thync Global Inc., U.S.A. 150
12.6.1 Company Overview 150
12.6.2 Financials 150
12.6.3 Products 150
12.6.4 Strategy 150
12.6.5 Key Developments 150
12.7 MoodMetric 151
12.7.1 Company Overview 151
12.7.2 Financials 151
12.7.3 Products 151
12.7.4 Strategy 151
12.7.5 Key Developments 151
13 Conclusion 152
13.1 Key Findings 152
13.1.1 CEO’s Viewpoint 152
13.1.2 Unmet Needs 152
13.1.3 Key Companies to Watch 152
13.1.4 Prediction of Biohacking Industry 152
14 Appendix 154
14.1 Discussion Blue Print 154
14.2 References 156
